Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Bladder Cancer
- B Cell Lymphoma
- Prostate Cancer
- Breast Cancer
- Cancer
- Colorectal Cancer
- Endometrial Cancer
- Esophageal Cancer
- Gastric Cancer
- Lung Cancer
- Melanoma
- Ovarian Cancer
- Glioblastoma
- Head and Neck Cancer
- Pancreatic Cancer
- Renal Cancer
- Hepatocellular Cancer
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Diagnostic
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03787056
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Benoit YOU, MD Hospices Civils de Lyon